Quest of biomarkers for venetoclax-treated CLL

Rossi Davide

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Quest of biomarkers for venetoclax-treated CLL

【24h】

Quest of biomarkers for venetoclax-treated CLL

机译：探索威尼替肽处理的CLL的生物标志物

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

In this issue of Blood, Roberts et al expand our understanding of prognostic biomarkers predicting the duration of remission in relapsed/refractory chronic lymphocytic leukemia (CLL) treated with venetoclax.

机译：在这个血液中，Roberts等人扩大了我们对预测用嘌呤醛葡萄糖处理的复发/难治性慢性淋巴细胞白血病（CLL）中缓解持续时间的预后生物标志物的理解。

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2019年第2期|共2页
作者
Rossi Davide;
展开▼
作者单位

Oncol Inst Southern Switzerland Ticino Switzerland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Quest of biomarkers for venetoclax-treated CLL [J] . Rossi Davide Blood: The Journal of the American Society of Hematology . 2019,第2期

机译：探索威尼替肽处理的CLL的生物标志物
2. Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice [J] . Roeker Lindsey E., Fox Christopher P., Eyre Toby A., Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第14期

机译：肿瘤裂解，不良事件和剂量调节在297例venetoclax处理的CLL患者常规临床实践中
3. Meta-analysis estimating the impact on progression-free survival (PFS) after frontline CLL fludarabine-based treatment according to the presence of high-risk biomarkers [J] . Fernandez de la Mata Margarita, Bello Lopez Jose Luis, Mosquera Orgueira Adrian, Leukemia and lymphoma . 2020,第S1期

机译：根据高风险生物标志物的存在，估计前线CLL氟拉西滨治疗后对无进展存活（PFS）的影响
4. Isolation and Detection of Cancer Related DNA Nanoparticulate Biomarkers Directly from CLL Patient Blood 'Rapid Sample to Sequence Diagnostics' [C] . Michael J. Heller, Jennifer Marciniak, Avery Sonnenberg Annual NSTI nanotechnology conference and expo . 2013

机译：直接从CLL患者血液中'快速样品到序列诊断'的癌症相关DNA纳米颗粒生物标志物的分离和检测
5. SMZL Phenotype Etiology Most Closely Resembles a Memory B-Cell and Parallels CLL in Key Aspects [D] . Stevenson, Nikolaus T. 2019

机译：SMZL表型病因最近最似乎在关键方面的记忆B细胞和Parallels CLL
6. Blood collection methods affect cellular protein integrity: implications for clinical trial biomarkers and ZAP-70 in CLL [O] . Lisa S. Chen, Michael J. Keating, Varsha Gandhi -1

机译：采血方法影响细胞蛋白质完整性：对CLL中临床试验生物标志物和ZAP-70的影响
7. Quest of biomarkers for venetoclax-treated CLL [O] . Davide Rossi 2019

机译：寻求威尼替肽处理的CLL的生物标志物
8. Biomarkers of Exposure to Toxic Substances. Volume 5: Biomarker Pre- validation Studies Prevalidation of Urine and Serum Biomarkers Indicative of Subclinical Kidney Damage in a Nephrotoxin Model [R] . Mauzy, C., Todd, D., Rono, V., 2009

机译：接触有毒物质的生物标志物。第5卷：生物标志物预验证研究尿液和血清生物标志物的预验证指示肾毒素模型中的亚临床肾损伤

Quest of biomarkers for venetoclax-treated CLL

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅